PO
CRDL

Private Ocean’s Cardiol Therapeutics CRDL Stock Holding History

Private Ocean’s Portfolio CRDL Stock Details CRDL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		$30.6K Hold
15,151
– – ﹤0.01% 306
2024
Q1 		$27.4K Hold
15,151
– – ﹤0.01% 292
2023
Q4 		$12.8K Hold
15,151
– – ﹤0.01% 345
2023
Q3 		$13.6K Hold
15,151
– – ﹤0.01% 339
2023
Q2 		$13.5K Hold
15,151
– – ﹤0.01% 368
2023
Q1 		$7.38K Hold
15,151
– – ﹤0.01% 427
2022
Q4 		$7.73K Sell
15,151
-5,500
-27% -$3.35K ﹤0.01% 392
2022
Q3 		$21K Hold
20,651
– – ﹤0.01% 306
2022
Q2 		$27K Hold
20,651
– – ﹤0.01% 272
2022
Q1 		$32K Hold
20,651
– – ﹤0.01% 295
2021
Q4 		$38K Buy
20,651
+15,151
+275% +$41.8K ﹤0.01% 300
2021
Q3 		$23K Buy
+5,500
New +$19.9K ﹤0.01% 337

Other funds holding CRDL

TC
Tejara Capital London, United Kingdom $303M AUM 5.43% 1-Year Est. Return
AI
AdvisorShares Investments Bethesda, Maryland $549M AUM 32.58% 1-Year Est. Return
MI
MMCAP International Grand Cayman, Cayman Islands $1.16B AUM 77.9% 1-Year Est. Return
LSA
Lion Street Advisors Austin, Texas $289M AUM 3.13% 1-Year Est. Return
Cambridge Investment Research Advisors
Cambridge Investment Research Advisors Fairfield, Iowa $38.8B AUM 21.88% 1-Year Est. Return
KCM
Knoll Capital Management Miami, Florida $180M AUM 66.11% 1-Year Est. Return
LNWTC
Laird Norton Wetherby Trust Company Seattle, Washington $4.58B AUM 30.77% 1-Year Est. Return
MOS
MGO One Seven Beachwood, Ohio $4.98B AUM 22.72% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return
UBS AM
UBS AM Chicago, Illinois $481B AUM 26.39% 1-Year Est. Return

Private Ocean's CRDL Position: Q2 2024 in Review

Private Ocean held its Cardiol Therapeutics (CRDL) position steady in Q2 2024 at 15,151 shares worth $30.6K. The position accounts for ﹤0.01% of the portfolio, ranked #306.

Private Ocean first reported a position in CRDL in Q3 2021 and has held it in 12 quarters since. The position peaked at $38K in Q4 2021. 41 funds tracked by Wall St. Rank hold CRDL as of Q2 2024.

  • Private Ocean held 15,151 shares of Cardiol Therapeutics worth $30.6K as of Q2 2024.
  • Private Ocean left its Cardiol Therapeutics share count unchanged in Q2 2024.
  • Cardiol Therapeutics made up ﹤0.01% of Private Ocean's portfolio in Q2 2024, its #306 holding.
  • Private Ocean first reported a position in Cardiol Therapeutics in Q3 2021 and has held it in 12 quarters since.
  • Private Ocean's Cardiol Therapeutics position peaked at $38K in Q4 2021.
  • 41 funds tracked by Wall St. Rank held Cardiol Therapeutics as of Q2 2024.

Based on Private Ocean's 13F filing for Q2 2024, filed 30 Jul 2024.